The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

Plus, if you’re 60 or older, you may be eligible for a vaccine to protect against RSV (respiratory syncytial virus), which can cause severe disease in the elderly and other vulnerable groups.

It starts with a sniffle. A mild cough. You tell yourself it’s just a cold—babies get those, right? But make no mistake. RSV ...

aNational Institute for Health and Care Research Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, UK bFaculty of Medicine ...

Colorado Springs Mayor Yemi Mobolade is recovering from a bout with double pneumonia and a cleared blocked artery procedure ...

Enflonsia is the first FDA-approved respiratory syncytial virus (RSV) preventative for infants, regardless of weight, according to the news release.